Pluristem Life Systems Inc. and Center for Regenerative Therapies at Charité University Hospital of Berlin Enters into Collaborative Research Agreement

NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS) (DAX:PJT), a bio-therapeutics Company dedicated to the commercialization of products for a variety of malignant, degenerative and auto-immune indications, announced today that it has entered into a Collaborative Research Agreement with the Berlin-Brandenburg Center for Regenerative Therapy (BCRT) at Charité - University Medicine Berlin.